Abstract B10: Fasting blood glucose and bone mineral density in Latina breast cancer survivors

Conclusion. In this limited sample size, FBG was not shown to be a predictive factor for decreased BMD in either premenopausal or postmenopausal LBCS, despite elevated FBG in postmenopausal LBCS. Our results differed from our hypothesis which, may be due to FBG levels that were only slightly elevated in LBCS with relatively healthy BMD. However, future investigations are warranted to further investigate whether elevated FBG is a risk factor for osteoporosis in larger sample of LBCS over a longer follow-up period.Table 1. Outcome MeasuresPRE LBCSFBG** 95.0±6.72 mg/dL*LSBMD T-score# -0.32±0.73RFBMD T-score# 0.33±0.34LFBMD T-score# 0.14±0.35POST LBCSFBG** 107.8±22.0 mg/dL*LSBMD T-score# -0.14±0.054RFBMD T-score# 0.25±0.42LFBMD T-score# 0.27±0.34**Means are ± SD; #Means are ± SE. *Means are statistically significantly different (p<0.05).Citation Format: Christina Dieli-Conwright, Lindsey Avery, Joanne Mortimer, Debu Tripathy, Darcy Spicer, Leslie Bernstein. Fasting blood glucose and bone mineral density in Latina breast cancer survivors. [abstract]. In: Proceedings of the Thirteenth Annual AACR International Conference on Frontiers in Cancer Prevention Research; 2014 Sep 27-Oct 1; New Orleans, LA. Philadelphia (PA): AACR; Can Prev Res 2015;8(10 Suppl): Abstract nr B10.
Source: Cancer Prevention Research - Category: Cancer & Oncology Authors: Tags: Quality of Life/Late Effects/Survivorship: Poster Presentations - Proffered Abstracts Source Type: research